[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Atlassian insider sale under 10b5-1 plan: Director and 10% owner Scott Farquhar reported multiple open-market sales of Class A common stock on 08/20/2025 executed pursuant to a Rule 10b5-1 plan adopted on 02/12/2025. The filings show four grouped transactions totaling 7,665 shares sold at weighted-average prices of $164.9655, $166.0434, $166.8908, and $167.9661. Shares are held indirectly through Farquhar Investment Partnership No. 2. The reported beneficial ownership decreased from 221,485 shares to a final 214,620 shares following these sales. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Positive
- Transactions executed under a documented Rule 10b5-1 plan, which supports non-suspicious, preauthorized trading.
- Detailed weighted-average prices and price ranges provided for each tranche, with an undertaking to provide full trade details on request.
- Form 4 discloses indirect ownership vehicle (Farquhar Investment Partnership No. 2), enhancing transparency.
Negative
- Insider sold 7,665 shares, reducing beneficial ownership from 221,485 to 214,620 shares, which is a tangible decrease in insider stake.
Insights
TL;DR: Director Farquhar executed preplanned, multiple open-market sales under a 10b5-1 plan; total 7,665 shares sold, modest ownership decrease.
These transactions were effected under a Rule 10b5-1 trading plan adopted February 12, 2025, and therefore indicate preauthorized dispositions rather than opportunistic insider trades. The sales occurred in four tranches on August 20, 2025, using weighted-average prices reported for each tranche. Beneficial ownership reported indirectly through Farquhar Investment Partnership No. 2 declined from 221,485 to 214,620 shares, a reduction of 6,865 shares relative to the first reported post-tranche figure. The activity is routine for large shareholders using trading plans and does not on its face disclose new company-specific material information.
TL;DR: A director and 10% owner completed systematic sales via a documented 10b5-1 plan; disclosure appears compliant and standard.
The Form 4 identifies the reporting person as both a director and a >10% owner and discloses that shares are held indirectly, which is important for governance transparency. The filer provided price ranges and undertook to supply transaction-level details upon request, aligning with robust disclosure practice. The signature by an attorney-in-fact is indicated. From a governance perspective, these are preplanned, disclosed sales and do not by themselves indicate governance concerns or undisclosed information.